NLM Digital Collections

Search

Start Over Genre Technical Report ✖Remove constraint Genre: Technical Report Publication Year 2021 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2021">2021</span>

691. Addressing needs of specific populations to improve patient and family engagement: 21 ways hospitals tailor family caregiver support by culture and condition

Author(s):
Reinhard, Susan C., author
Young, Heather M., author
Choula, Rita B., author
Drenkard, Karen, author
Suereth, Beth R., author
Publication:
Washington, DC : AARP Public Policy Institute, November 2021
Subject(s):
Caregivers -- education
Cultural Competency
Culturally Competent Care
United States

692. Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report

Author(s):
Tice, Jeffrey A., author
Agboola, Foluso, author
Herron-Smith, Serina, author
Chapman, Rick, (Of Institute for Clinical and Economic Review), author
Pearson, Steven D., author
Mandrik, Olena, author
Thokala, P. (Praveen), author
Fotheringham, James, (Of University of Sheffield), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 16, 2021
Subject(s):
Antibodies, Monoclonal, Humanized
B-Cell Activating Factor -- antagonists & inhibitors
Calcineurin Inhibitors -- therapeutic use
Cyclosporine -- therapeutic use
Immunosuppressive Agents -- therapeutic use
Lupus Nephritis -- drug therapy
Treatment Outcome
United States

693. Treatments for anemia in chronic kidney disease: effectiveness and value : final evidence report

Author(s):
Mustafa, Reem A., author
Fox, Grace, (Of Institute for Clinical and Economic Review), author
Campbell, Jonathan D., author
Agboola, Foluso, author
Pearson, Steven D., author
Rind, David M., author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 5, 2021
Subject(s):
Glycine -- analogs & derivatives
Hematinics -- therapeutic use
Isoquinolines -- therapeutic use
Hypoxia-Inducible Factor-Proline Dioxygenases -- antagonists & inhibitors
Anemia, Iron-Deficiency -- drug therapy
Renal Insufficiency, Chronic -- complications
Renal Insufficiency, Chronic -- drug therapy
Treatment Outcome
United States

694. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

Author(s):
Lin, Grace A., author
Jih, Jane, author
Agboola, Foluso, author
Peason, Steven D., author
Kazi, Dhruv S., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 2, 2021
Subject(s):
Anticholesteremic Agents -- therapeutic use
Atherosclerosis -- prevention & control
ATP Citrate (pro-S)-Lyase -- antagonists & inhibitors
Dicarboxylic Acids -- therapeutic use
Fatty Acids
Hyperlipoproteinemia Type II -- drug therapy
RNA, Small Interfering
Secondary Prevention
Treatment Outcome
Drug Therapy Combination
Ezetimibe -- therapeutic use
United States